Beijing Tong Ren Tang Receives Canadian Production Site Certification and Product Approval

Stock News06-05

Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its subsidiary branch, Beijing Tong Ren Tang Co., Ltd. Tong Ren Tang Pharmaceutical Factory, has obtained a Foreign Site Certification from Health Canada.

This certification signifies that the factory's production system now meets Canada's quality management requirements for the manufacturing of natural health products at foreign sites.

Concurrently, two of the pharmaceutical factory's products, Yangyin Qingfei Wan and Shiyi Qingwen Wan, have received approval to be marketed and sold in Canada.

These developments are expected to have a positive impact on the company's efforts to expand its market presence in Canada.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment